37 related articles for article (PubMed ID: 2501244)
1. Overexpression and amplification of the c-myc gene in mouse tumors induced by chemicals and radiations.
Niwa O; Enoki Y; Yokoro K
Jpn J Cancer Res; 1989 Mar; 80(3):212-8. PubMed ID: 2470712
[TBL] [Abstract][Full Text] [Related]
2. Effect of human interferons on morphological differentiation and suppression of N-myc gene expression in human neuroblastoma cells.
Watanabe H; Chisaka T; Higuchi T; Tanaka A; Horii Y; Sugimoto T; Imanishi J
Jpn J Cancer Res; 1989 Nov; 80(11):1072-6. PubMed ID: 2481662
[TBL] [Abstract][Full Text] [Related]
3. MYC-family protein overexpression and prominent nucleolar formation represent prognostic indicators and potential therapeutic targets for aggressive high-MKI neuroblastomas: a report from the children's oncology group.
Niemas-Teshiba R; Matsuno R; Wang LL; Tang XX; Chiu B; Zeki J; Coburn J; Ornell K; Naranjo A; Van Ryn C; London WB; Hogarty MD; Gastier-Foster JM; Look AT; Park JR; Maris JM; Cohn SL; Seeger RC; Asgharzadeh S; Ikegaki N; Shimada H
Oncotarget; 2018 Jan; 9(5):6416-6432. PubMed ID: 29464082
[TBL] [Abstract][Full Text] [Related]
4. Autoantibody signature differentiates Wilms tumor patients from neuroblastoma patients.
Schmitt J; Keller A; Nourkami-Tutdibi N; Heisel S; Habel N; Leidinger P; Ludwig N; Gessler M; Graf N; Berthold F; Lenhof HP; Meese E
PLoS One; 2011; 6(12):e28951. PubMed ID: 22194956
[TBL] [Abstract][Full Text] [Related]
5. The connections between neural crest development and neuroblastoma.
Jiang M; Stanke J; Lahti JM
Curr Top Dev Biol; 2011; 94():77-127. PubMed ID: 21295685
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of the in vivo alkylating agent resistant murine EMT-6 mammary carcinoma tumors.
Chatterjee D; Liu CJ; Northey D; Teicher BA
Cancer Chemother Pharmacol; 1995; 35(5):423-31. PubMed ID: 7850925
[TBL] [Abstract][Full Text] [Related]
7. Co-amplification of c-myc and c-erbB-2 oncogenes in a poorly differentiated human gastric cancer.
Tsuchiya T; Ueyama Y; Tamaoki N; Yamaguchi S; Shibuya M
Jpn J Cancer Res; 1989 Oct; 80(10):920-3. PubMed ID: 2575609
[TBL] [Abstract][Full Text] [Related]
8. Coamplification of the L-myc and N-myc oncogenes in a neuroblastoma cell line.
Jinbo T; Iwamura Y; Kaneko M; Sawaguchi S
Jpn J Cancer Res; 1989 Apr; 80(4):299-301. PubMed ID: 2501244
[TBL] [Abstract][Full Text] [Related]
9. Where pathology meets molecular biology: N-myc amplification in human neuroblastoma as a paradigm for the clinical use of an oncogene alteration.
Schwab M
Verh Dtsch Ges Pathol; 1994; 78():26-33. PubMed ID: 7533996
[TBL] [Abstract][Full Text] [Related]
10. Inverse correlation between expression of multidrug resistance gene and N-myc oncogene in human neuroblastomas.
Nakagawara A; Kadomatsu K; Sato S; Kohno K; Takano H; Akazawa K; Nose Y; Kuwano M
Cancer Res; 1990 May; 50(10):3043-7. PubMed ID: 2185879
[TBL] [Abstract][Full Text] [Related]
11. Sequence of a germ-line N-myc gene and amplification as a mechanism of activation.
Ibson JM; Rabbitts PH
Oncogene; 1988 Apr; 2(4):399-402. PubMed ID: 2834684
[TBL] [Abstract][Full Text] [Related]
12. [Amplification of N-myc in neuroblastoma: paradigm for clinical use of an oncogene alteration].
Schwab M
Klin Padiatr; 1990; 202(4):197-201. PubMed ID: 2203936
[TBL] [Abstract][Full Text] [Related]
13. Specific expression of the ret proto-oncogene in human neuroblastoma cell lines.
Ikeda I; Ishizaka Y; Tahira T; Suzuki T; Onda M; Sugimura T; Nagao M
Oncogene; 1990 Sep; 5(9):1291-6. PubMed ID: 2216455
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
